av/biocon--big.svg

COM:BIOCON

Biocon

  • Stock

INR

Last Close

321.80

02/05 08:51

Market Cap

425.67B

Beta: -

Volume Today

1.12M

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Mar '15
Mar '16
Mar '17
Mar '18
Mar '19
Mar '20
Mar '21
Mar '22
Mar '23
Mar '24
Mar '25
average inventory
4.15B
-
4.82B
16.25%
5.73B
18.94%
6.79B
18.41%
8.77B
29.19%
12.34B
40.67%
16.51B
33.84%
20.82B
26.11%
32.71B
57.08%
45.94B
40.44%
49.38B
7.48%
average payables
3.88B
-
4.88B
25.74%
6.43B
31.79%
8.72B
35.61%
11.02B
26.28%
12.62B
14.51%
14.20B
12.51%
15.61B
9.98%
27.96B
79.08%
50.57B
80.88%
64.10B
26.76%
average receivables
8.47B
-
10.24B
20.83%
11.94B
16.67%
13.59B
13.78%
20.04B
47.45%
12.85B
35.88%
13.66B
6.31%
31.98B
134.16%
36.54B
14.26%
49.02B
34.14%
58.59B
19.53%
book value per share
27.25
-
34.43
26.34%
41.07
19.29%
43.91
6.90%
51.53
17.36%
56.63
9.90%
64.25
13.45%
70.80
10.20%
149.82
111.62%
211.34
41.06%
231.37
9.48%
capex per share
-7.64
-
-8.30
8.58%
-6.47
22.01%
-7.77
20.04%
-12.61
62.32%
-15.51
23.01%
-14.71
5.15%
-16.16
9.86%
-14.48
10.42%
16.15
211.58%
19.56
21.13%
capex to depreciation
-4.15
-
-4.03
2.79%
-2.75
31.83%
-2.38
13.44%
-3.33
40.00%
-3.33
0.18%
-2.44
26.57%
-2.36
3.19%
-1.55
34.40%
1.23
179.39%
1.39
12.81%
capex to operating cash flow
-4.35
-
-1.86
57.34%
-1.19
35.85%
-1.38
16.25%
-1.29
6.65%
-1.43
10.76%
-1.51
5.21%
-1.64
8.64%
-0.93
43.04%
0.65
170.17%
0.58
11.76%
capex to revenue
-0.30
-
-0.29
4.25%
-0.20
30.95%
-0.23
16.26%
-0.28
20.35%
-0.30
6.63%
-0.25
15.26%
-0.24
4.26%
-0.15
35.59%
0.13
184.73%
0.16
18.92%
cash per share
9.72
-
19.94
105.05%
17.90
10.22%
16.39
8.47%
9.93
39.39%
8.90
10.40%
22.22
149.73%
16.78
24.50%
32.36
92.84%
26.02
19.58%
41.94
61.18%
days of inventory on hand
131.31
-
140.08
6.68%
160.07
14.27%
160.97
0.56%
198.29
23.19%
255.13
28.66%
308.26
20.83%
307.99
0.09%
422.85
37.29%
323.26
23.55%
346.29
7.12%
days payables outstanding
124.52
-
149.86
20.35%
186.38
24.37%
223.97
20.17%
230.33
2.84%
235.44
2.22%
250.01
6.19%
215.56
13.78%
396.89
84.12%
410.10
3.33%
459.89
12.14%
days sales outstanding
111.97
-
118.88
6.17%
121.47
2.18%
131.95
8.62%
174.29
32.09%
143.05
-
166.69
16.53%
119.02
28.60%
154.12
29.50%
133.08
13.66%
debt to assets
0.17
-
0.29
67.67%
0.25
16.10%
0.23
7.53%
0.20
12.31%
0.19
5.40%
0.24
28.69%
0.25
4.31%
0.35
37.20%
0.28
18.98%
0.31
11.32%
debt to equity
0.34
-
0.61
79.88%
0.48
22.09%
0.44
8.18%
0.40
9.07%
0.40
1.91%
0.59
45.10%
0.61
3.88%
1.01
65.24%
0.80
21.16%
0.85
6.70%
dividend yield
0.01
-
0.02
73.69%
0.00
-
0.00
2.94%
0.00
1.14%
0.00
-
0.01
115.71%
0.00
67.57%
earnings yield
0.05
-
0.09
78.22%
0.03
70.84%
0.01
61.70%
0.02
134.17%
0.02
5.44%
0.02
34.68%
0.02
6.33%
0.03
61.09%
0.03
21.32%
0.02
21.30%
enterprise value
100.35B
-
108.40B
8.02%
238.20B
119.74%
370.72B
55.63%
383.49B
3.44%
338.43B
11.75%
520.70B
53.86%
444.56B
14.62%
413.03B
7.09%
472.97B
14.51%
557.51B
17.87%
enterprise value over ebitda
13.54
-
12.14
10.38%
20.96
72.69%
37.18
77.38%
25.21
32.19%
19.58
22.33%
31.08
58.70%
22.63
27.18%
15.18
32.91%
11.39
24.98%
12.47
9.48%
ev to operating cash flow
47.63
-
20.59
56.76%
37.22
80.74%
55.99
50.44%
33.21
40.68%
26.38
20.59%
44.90
70.23%
37.78
15.85%
22.30
40.99%
16.01
28.19%
13.73
14.26%
ev to sales
3.28
-
3.18
2.95%
6.19
94.55%
9.32
50.46%
7.13
23.53%
5.45
23.55%
7.47
37.11%
5.54
25.84%
3.70
33.28%
3.21
13.28%
3.70
15.55%
free cash flow per share
-5.88
-
-3.83
34.96%
-1.04
72.91%
-2.16
107.98%
-2.85
32.24%
-4.67
63.91%
-4.94
5.73%
-6.28
27.13%
1.06
116.85%
8.55
707.77%
14.34
67.78%
free cash flow yield
-0.08
-
-0.05
36.85%
-0.01
88.44%
-0.01
31.16%
-0.01
27.76%
-0.02
87.66%
-0.01
30.04%
-0.02
54.89%
0.01
127.40%
0.03
518.04%
0.04
33.44%
graham net net
-6.96
-
-5.76
17.22%
-6.75
17.03%
-8.20
21.64%
-15.78
92.32%
-44.67
183.06%
-37.02
17.12%
-42.21
14.03%
-174.76
314.01%
-171.75
1.73%
-162.64
5.30%
graham number
50.42
-
76.78
52.28%
69.30
9.73%
55.84
19.43%
94.18
68.66%
89.73
4.73%
94.96
5.83%
93.12
1.93%
134.82
44.78%
178.39
32.32%
185.46
3.96%
income quality
0.34
-
0.43
27.03%
0.93
116.87%
1.46
57.11%
1.15
21.19%
1.47
27.93%
1.37
6.98%
1.52
11.27%
2.88
88.93%
2.89
0.27%
2.84
1.65%
intangibles to total assets
0.04
-
0.03
16.64%
0.04
32.88%
0.06
47.43%
0.07
14.59%
0.07
8.69%
0.06
12.47%
0.06
0.47%
0.51
694.47%
0.48
7.19%
0.46
3.21%
interest coverage
151.13
-
-1.15K
859.97%
22.19
101.93%
4.11
81.50%
9.65
135.00%
17.55
81.96%
16.65
5.17%
17.02
2.22%
3.84
77.45%
5.22
35.98%
1.48
71.55%
interest debt per share
9.28
-
21.03
126.73%
19.77
6.00%
19.74
0.13%
21.07
6.72%
23.50
11.51%
38.23
62.72%
43.78
14.50%
154.61
253.18%
139.68
9.66%
160.80
15.12%
inventory turnover
2.78
-
2.61
6.27%
2.28
12.49%
2.27
0.55%
1.84
18.82%
1.43
22.28%
1.18
17.24%
1.19
0.09%
0.86
27.16%
1.13
30.81%
1.05
6.65%
invested capital
0.34
-
0.61
79.88%
0.48
22.09%
0.44
8.18%
0.40
9.07%
0.40
1.91%
0.59
45.10%
0.61
3.88%
1.01
65.24%
384.57B
38,133,101,725,320.12%
424.24B
10.31%
market cap
93.86B
-
94.88B
1.09%
222.27B
134.25%
353.08B
58.85%
366.54B
3.81%
320.37B
12.60%
485.42B
51.52%
399.72B
17.65%
246.08B
38.44%
322.54B
31.07%
406.16B
25.93%
net current asset value
-3.70B
-
-1.22B
67.14%
-1.33B
9.13%
-1.93B
45.14%
-6.63B
244.08%
-17.36B
161.91%
-24.14B
39.10%
-25.42B
5.28%
-172.20B
577.50%
-156.17B
9.31%
-147.99B
5.24%
net debt to ebitda
0.88
-
1.51
72.86%
1.40
7.39%
1.77
26.17%
1.11
37.02%
1.04
6.18%
2.11
101.52%
2.28
8.39%
6.14
168.85%
3.62
40.97%
3.39
6.56%
net income per share
4.14
-
7.61
83.55%
5.20
31.69%
3.16
39.27%
7.65
142.39%
6.32
17.41%
6.24
1.28%
5.44
12.73%
5.39
0.95%
8.55
58.57%
8.46
1.05%
operating cash flow per share
1.76
-
4.47
154.54%
5.43
21.58%
5.61
3.27%
9.76
73.87%
10.84
11.06%
9.77
9.85%
9.88
1.12%
15.53
57.25%
24.70
59.00%
33.91
37.27%
payables turnover
2.93
-
2.44
16.91%
1.96
19.59%
1.63
16.78%
1.58
2.76%
1.55
2.17%
1.46
5.83%
1.69
15.98%
0.92
45.69%
0.89
3.22%
0.79
10.83%
receivables turnover
3.26
-
3.07
5.81%
3.00
2.14%
2.77
7.94%
2.09
24.29%
2.55
-
2.19
14.18%
3.07
40.06%
2.37
22.78%
2.74
15.81%
research and ddevelopement to revenue
0.07
-
0.08
23.22%
0.04
51.84%
0.01
76.80%
0.03
188.28%
0.05
90.95%
0.06
14.40%
0.06
10.56%
0.05
12.42%
0.08
52.86%
0.01
88.31%
return on tangible assets
0.08
-
0.11
34.57%
0.07
37.69%
0.04
41.62%
0.08
101.03%
0.06
29.79%
0.04
23.58%
0.03
20.50%
0.03
25.46%
0.03
37.23%
0.03
8.17%
revenue per share
25.49
-
28.91
13.40%
32.65
12.95%
33.72
3.26%
45.47
34.87%
52.46
15.36%
58.71
11.93%
67.37
14.75%
93.70
39.08%
123.39
31.68%
125.67
1.85%
roe
0.15
-
0.22
45.29%
0.13
42.74%
0.07
43.19%
0.15
106.53%
0.11
24.84%
0.10
12.98%
0.08
20.80%
0.04
53.20%
0.05
43.61%
0.05
9.42%
roic
0.07
-
0.06
20.67%
0.07
17.68%
0.03
58.88%
0.07
144.80%
0.09
37.86%
0.06
31.29%
0.07
4.70%
0.03
51.18%
0.12
281.96%
0.02
83.39%
sales general and administrative to revenue
0.03
-
0.02
25.87%
0.02
10.71%
0.03
40.58%
0.02
16.32%
0.02
12.32%
0.04
48.96%
0.02
35.81%
0.02
1.86%
0.18
661.42%
shareholders equity per share
27.25
-
34.43
26.34%
41.07
19.29%
43.91
6.90%
51.53
17.36%
56.63
9.90%
64.25
13.45%
70.80
10.20%
149.82
111.62%
165.43
10.42%
180.70
9.23%
stock based compensation to revenue
0.00
-
0.00
93.17%
0.01
82.57%
0.01
9.39%
0.01
19.44%
0.01
72.47%
0.02
44.66%
0.02
3.00%
0.01
21.39%
0.01
44.63%
0.01
33.50%
tangible asset value
32.11B
-
41.09B
27.99%
48.35B
17.66%
50.55B
4.54%
58.77B
16.26%
63.14B
7.44%
73.08B
15.74%
81.55B
11.59%
-41.73B
151.18%
-13.84B
66.83%
6.55B
147.31%
tangible book value per share
26.76
-
34.89
30.40%
41.05
17.66%
42.84
4.36%
49.66
15.92%
53.32
7.37%
61.56
15.44%
68.47
11.23%
-35.00
151.11%
-11.58
66.92%
5.47
147.24%
working capital
10.08B
-
23.66B
134.71%
23.69B
0.16%
20.07B
15.28%
17.85B
11.06%
13.17B
26.23%
33.90B
157.43%
45.54B
34.33%
38.23B
16.05%
-1.80B
104.70%
19.52B
1,187.08%

All numbers in INR (except ratios and percentages)